ARTICLE | Company News
Medtronic, Yamanouchi Pharmaceutical Co. Ltd deal
August 25, 2003 7:00 AM UTC
Yamanouchi granted MDT exclusive commercialization rights to its implantable recombinant human bone morphogenic protein (rhBMP-2) for use in orthopedic surgery in Asia. MDT's Japanese subsidiary, Medt...